ASX:GSS

Genetic Signatures (GSS) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
GSS stock logo

About Genetic Signatures Stock (ASX:GSS)

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, it offers detection kits for gastrointestinal infections, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical disease. Genetic Signatures Limited was incorporated in 2001 and is headquartered in Newtown, Australia.

GSS Stock News Headlines

New Trump Bombshell
I believe Donald J. Trump will go down as America’s last Republican president. But NOT for the reasons you may think…
Genetic Counselor Salary
Genetic Signatures Ltd GSS
New Trump Bombshell
I believe Donald J. Trump will go down as America’s last Republican president. But NOT for the reasons you may think…
DNA Confirms Oral History of Swahili People
Genetic Signatures Ltd (GSS)
See More Headlines
Receive GSS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genetic Signatures and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
1,626
Year Founded
N/A

Profitability

Net Income
$-18,040,000.00
Net Margins
-112.83%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$15.99 million
Book Value
A$0.28 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.12
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Dr. John R. Melki BSc
    Ph.D., MD, CEO & Executive Director
  • Mr. Michael Anton Aicher BSc (Age 64)
    M.B.A., MBA, Executive Director of US Operations & Executive Director
    Comp: $178.42k
  • Mr. Christopher M. Abbott
    Founder & Chairman Emeritus
  • Mr. Karl David Pechmann
    CFO, COO & Company Secretary
  • Dr. Douglas S. Millar BSc
    Ph.D., Chief Scientific Officer
  • Ms. Rebecca Abbatantuono
    Global Head of People & Culture
  • Ms. Neralie Coulston B.Sc.
    Global Head of Regulatory Affairs
  • Mr. Jackson Jones B.Sc.
    Chief Commercial Officer

This page (ASX:GSS) was last updated on 5/2/2024 by MarketBeat.com Staff

From Our Partners